Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI)

Clinical Trial ID NCT03829462

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03829462

Top papers